[Biobanking and Biomolecular Resources Research Infrastructure (BBMRI). Implications for pathology].
High quality human biological samples (e.g. blood, tissue or DNA) with associated, well documented clinical and research data are key resources for advancement of life sciences, biotechnology, clinical medicine, drug development and also molecular pathology. Millions of samples of diseased tissues have been collected in the context of routine histopathological diagnosis and are stored in the archives of hospitals and institutes of pathology. A concerted effort is necessary to overcome the current fragmentation of the European biobanking community in order to tap the full research potential of existing biobanks. A pan-European research infrastructure for biobanking and biomolecular resources (BBMRI) is currently in its planning phase. The mission is to link and provide access to local biobanks of different formats, including tissue collections, harmonize standards, establish operational procedures which properly consider ethical, legal, societal aspects, and to secure sustainable funding. Pathology plays a key role in development and administration of tissue banks and is, thus, a major partner for collaboration, expertise and construction of this pan-European research infrastructure.
Viertler
C
C
Institut für Pathologie, Medizinische Universität Graz, Osterreich.
Zatloukal
K
K
D018070:Biological Specimen Banks / Q000458:organization & administration*; D001709:Biotechnology / Q000458:organization & administration*; D019295:Computational Biology; D005060:Europe; D006801:Humans; D007391:International Cooperation; D010338:Pathology, Clinical; D012106:Research / Q000458:organization & administration*; D014015:Tissue Banks / Q000458:organization & administration*